P. E. O. Fonseca, J. A. Azevedo, S. M. G. Bié, and S. B. Ferreira, “Benefits of using SLGT2 Inhibitors for Patients with CDK and DM2 to Reduce Mortality Risks”, Arch Pharm Pharma Sci, vol. 8, no. 1, pp. 041–046, May 2024.